Literature DB >> 26218915

Assessment of Proteins Associated With Complement Activation and Inflammation in Maculae of Human Donors Homozygous Risk at Chromosome 1 CFH-to-F13B.

Tiarnan D L Keenan1, Marc Toso2, Chris Pappas2, Lisa Nichols2, Paul N Bishop3, Gregory S Hageman2.   

Abstract

PURPOSE: To determine the effects of chromosome 1 genotype and cigarette smoking on levels of complement activation and inflammation in the human macula.
METHODS: Donor macular tissue was stratified into three groups by diplotype at the AMD-associated CFH-to-F13B locus: homozygous "risk" (n = 9, 56-78 years), homozygous neutral (n = 2, 64-79 years), and homozygous "protective" (n = 6, 61-78 years) diplotype. Importantly, all donors were homozygous nonrisk at the ARMS2/HTRA1 locus, so that purely chromosome 1-directed pathways were examined. Immunohistochemistry was performed by using 14 antibodies, mostly against markers of complement and inflammation, followed by confocal microscopy and immunofluorescence quantification (all masked to donor status).
RESULTS: Donors homozygous risk at CFH-to-F13B exhibited significantly higher levels of terminal complement complex (TCC) in macular Bruch's membrane (BM; P = 0.03), choriocapillaris (CC; P = 0.04), and choriocapillaris intercapillary septa (CC IS; P = 0.03), compared to homozygous protected donors. Smoking was associated with increased TCC in BM (P = 0.05), CC IS (P = 0.03), and choroidal stroma (CS; P = 0.01), and with substantially elevated C-reactive protein (CRP) levels in RPE (P = 0.04), BM (P = 0.01), CC (P = 0.05), and CS (P = 0.05). Smoking was associated with higher levels of oxidative stress in macular RPE (P = 0.04) and CS (P = 0.01).
CONCLUSIONS: Genetic risk at the CFH-to-F13B locus was associated with higher levels of complement activation at the human macular RPE-choroid interface, as was cigarette smoking. Levels of CRP were substantially elevated in risk donors with smoking history. Examination of human macular tissue from donors with "pure" diplotypes allows assessment of AMD-associated pathways driven solely by CFH-to-F13B. These findings have important implications for identifying chromosome 1-directed pathways and therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26218915     DOI: 10.1167/iovs.15-17009

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

1.  Association Between C-Reactive Protein and Age-Related Macular Degeneration: Les Liaisons Dangereuses.

Authors:  Tiarnán D Keenan; Emily Y Chew
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

2.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Mast cell infiltration of the choroid and protease release are early events in age-related macular degeneration associated with genetic risk at both chromosomes 1q32 and 10q26.

Authors:  Selina Mcharg; Laura Booth; Rahat Perveen; Isabel Riba Garcia; Nicole Brace; Nadhim Bayatti; Panagiotis I Sergouniotis; Alexander M Phillips; Anthony J Day; Graeme C M Black; Simon J Clark; Andrew W Dowsey; Richard D Unwin; Paul N Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-13       Impact factor: 12.779

4.  Integrating external controls in case-control studies improves power for rare-variant tests.

Authors:  Yatong Li; Seunggeun Lee
Journal:  Genet Epidemiol       Date:  2022-02-16       Impact factor: 2.344

Review 5.  The complement system in age-related macular degeneration.

Authors:  Angela Armento; Marius Ueffing; Simon J Clark
Journal:  Cell Mol Life Sci       Date:  2021-03-09       Impact factor: 9.261

Review 6.  The eye as a complement dysregulation hotspot.

Authors:  Simon J Clark; Paul N Bishop
Journal:  Semin Immunopathol       Date:  2017-09-25       Impact factor: 9.623

7.  Bruch's Membrane Compartmentalizes Complement Regulation in the Eye with Implications for Therapeutic Design in Age-Related Macular Degeneration.

Authors:  Simon J Clark; Selina McHarg; Viranga Tilakaratna; Nicole Brace; Paul N Bishop
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

8.  Active Rap1-mediated inhibition of choroidal neovascularization requires interactions with IQGAP1 in choroidal endothelial cells.

Authors:  Aniket Ramshekar; Haibo Wang; Eric Kunz; Christian Pappas; Gregory S Hageman; Brahim Chaqour; David B Sacks; M Elizabeth Hartnett
Journal:  FASEB J       Date:  2021-07       Impact factor: 5.834

9.  C-reactive protein and pentraxin-3 binding of factor H-like protein 1 differs from complement factor H: implications for retinal inflammation.

Authors:  Maurice Swinkels; Justine H Zhang; Viranga Tilakaratna; Graeme Black; Rahat Perveen; Selina McHarg; Antonio Inforzato; Anthony J Day; Simon J Clark
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

Review 10.  C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

Authors:  Blanca Molins; Sara Romero-Vázquez; Pablo Fuentes-Prior; Alfredo Adan; Andrew D Dick
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.